PROTAC EZH2 degrader-1 overcomes the resistance of podophyllotoxin derivatives in refractory small cell lung cancer with leptomeningeal metastasis
Article in BMC Cancer (April 2024)
The most recent citing publications are shown below. View all 76 publications that cite this research output on Dimensions.
Article in BMC Cancer (April 2024)
Article in European Journal of Pharmaceutics and Biopharmaceutics (January 2024)
Article in Journal of Controlled Release (December 2023)